I.B.N. Savio owns a broad portfolio of pharmaceutical and, more broadly, healthcare products, which it promotes directly through its Savio Pharma Italia division or licenses to third-party companies for commercialization in both domestic and international markets. The company also oversees the full distribution of its products across the country, relying on highly qualified and specialized partners to ensure efficient and professional deliveries.
-
ARBUX - Febuxostat - Class A - RR - Note 91
-
ASSORAL - Roxithromycin - Class A - RR
Musculoskeletal
-
ATHENAVIS 2000 - Hyaluronic Acid - Medical Device
-
Athenavis One Hyaluronic Acid 1.5% 4 ml> 2000kDa - MEDICAL DEVICE
-
Athenavis Plus - Hyaluronic Acid 2% 800-1,300kDa - MEDICAL DEVICE
- Endocrine-metabolic
-
BILIVER - Bacillus Clausii SF174, Plant Extracts, Chromium, Vit. B12 - Supplement
-
BUDINEB - Budesonide - Class A - RR
Anti-infective
-
CLAVULIN - Amoxicillin + Clavulanic Acid - Class A (RR)